BDX
Becton, Dickinson and Co.
NYSE · usd
Becton, Dickinson and Co. (BDX) trades at $214.52 (+0.90%) as of 7:51:30 PM EST on Nov 11, 2026, +14.49% over the past month. Market cap is $57.91B, with 5.2 days to cover in short interest.
Stock performance
How Becton, Dickinson and Co. (BDX) stock has performed from one day to one year, with its 52-week range.
- 1D
- +0.90%
- 1W
- +2.55%
- 1M
- +14.49%
- YTD
- +10.54%
- 1Y
- +11.66%
- 52-wk range
- $140.11 – $216.74
Key statistics
Today's trading snapshot for BDX: day range, open, previous close, volume and market cap.
- Day range
- $209.00 – $214.88
- Open
- $210.06
- Prev close
- $212.61
- Volume
- 1.64M
- Market cap
- $57.91B
- Shares out
- 275.54M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Becton, Dickinson and Co.: P/E, P/S, P/B, ROE and more.
- P/E
- 61.54
- P/S
- 2.78
- P/B
- 2.37
- P/FCF
- 22.87
- ROE
- 3.9%
- ROA
- 1.8%
- Debt/Equity
- 0.69
- Div yield
- 2.02%
As of Nov 10, 2026
8-K filings
Material corporate events Becton, Dickinson and Co. has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 5, 2026
On November 5, 2026, Becton, Dickinson and Company ("BD") issued a press release announcing its financial results for its fourth fiscal quarter ending September 30, 2026.
- Executive officer departureJul 22, 2026
On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company ('BD'), informed BD of his intention to retire. Dr. Garrison will remain in his role through the end of the fiscal year to support a smooth transition.
- Regulatory decisionMay 29, 2026
The Company had placed the products on ship hold to implement additional release testing, in response to the Warning Letter received from the FDA for the El Paso manufacturing facility (the 'El Paso Warning Letter').
- Debt issuanceMay 20, 2026
On May 20, 2026, Becton Dickinson Euro Finance S.à r.l., a private limited liability company incorporated under the laws of the Grand Duchy of Luxembourg ('Becton Finance') and an indirect, wholly-owned subsidiary of Becton, Dickinson and Company ('BD'), issued €600,000,000 aggregate principal amount of its 3.855% Notes due 2033 (the 'Becton Finance Notes') in an underwritten public offering.
- Underwriting agreementMay 12, 2026
On May 11, 2026, Becton, Dickinson and Company, together with its indirect, wholly-owned subsidiary, Becton Dickinson Euro Finance S.à r.l., entered into an underwriting agreement with Barclays Bank PLC, BNP PARIBAS, Goldman Sachs & Co. LLC and Morgan Stanley & Co. International plc and the several other underwriters named therein.
Dividend history and stock splits
Becton, Dickinson and Co.'s recent dividend payments and stock splits.
Dividends
- $1.06ex-div Dec 10, 2026
- $1.05ex-div Sep 9, 2026
- $1.05ex-div Jun 9, 2026
- $1.05ex-div Mar 10, 2026
Splits
No recent splits.
BDX short interest
How heavily BDX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 5.2
- Short interest
- 8.11M
- Avg volume
- 1.56M
As of · reported to FINRA twice monthly.
BDX news
The latest news and headlines about Becton, Dickinson and Co. (BDX).
- Global Injectables Market is Anticipated to Surpass USD 1 Trillion Mark by 2034 | DelveInsightpositiveGlobeNewswire Inc.· Nov 11, 2026
- 3 Stocks in Focus That Hiked Dividends Amid Ongoing Market VolatilitypositiveZacks Investment Research· Nov 6, 2026
- BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue BeatneutralZacks Investment Research· Nov 5, 2026
- BDX Gears Up to Report Q4 Results: How to Play the Stock?neutralZacks Investment Research· Nov 3, 2026
- Mettler-Toledo's Q3 Earnings on Deck: What's in Store for the Stock?positiveZacks Investment Research· Nov 3, 2026
Frequently asked questions
What is the Becton, Dickinson and Co. (BDX) stock price today?
Becton, Dickinson and Co. (BDX) is trading at $214.52 (+0.90% on the day) as of 7:51:30 PM EST on Nov 11, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Becton, Dickinson and Co.?
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products.
What is the short interest in BDX?
As of Oct 30, 2026, BDX has 8.11M shares short and 5.2 days to cover.
Does Becton, Dickinson and Co. (BDX) pay a dividend?
Yes. Becton, Dickinson and Co. (BDX)'s most recent dividend was $1.06 per share, with an ex-dividend date of Dec 10, 2026. Full BDX dividend history is available from the Massive API.
What exchange is BDX listed on?
Becton, Dickinson and Co. (BDX) trades on NYSE in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of BDX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BDX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.